Carlsquare Equity Research is positive regarding the recent news that a patent for the drug delivery technology has been submitted. Furthermore, more information was shared regarding the different indications being tested. Among others, drugs for Alzheimer’s and epilepsy were tested.

Read the full comment here.

About Carlsquare

Carlsquare is a global research firm and financial advisor, focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 150 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience about the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more

Contacts

MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20
 
NIKLAS ELMHAMMER
Senior Equity Analyst
niklas.elmhammer@carlsquare.com
+46 (0)70 898 39 59

Attachments

Mrkt BUZZ Nosa Plugs: Drug Delivery patent submitted